Perrigo's Next Private Label First Lands With Second Thoughts On Outlook

The launch of a private label version 24HR OTC heartburn treatment comes with Perrigo in need of another high-selling product to boost revenues in its core business, OTC private label. But analysts call for Perrigo to do more to grow in new markets.

Perrigo Co. PLC is optimistic that its newly launched private label version of Nexium 24HR OTC heartburn treatment will provide a needed boost to its core business of OTC private label products. It's both the first-to-market OTC generic version of the product and builds on much higher brand sales than other previous private label launches of proton pump inhibitors.

Esomeprazole magnesium 20 mg delayed-release capsules, indicated to treat frequent heartburn, is now available to US retailers, Perrigo said on...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Growing With Purpose – Inside Kenvue’s ‘Healthy Lives Mission’

 
• By 

HBW Insight speaks to Kenvue's global head of sustainability, Jennifer Duran, about the company's “Healthy Lives Mission,” including insights into how the firm is decarbonizing its supply chain, reducing the use of plastics and embedding sustainability into the design of new products.

Scent News: Givaudan Buys Brazilian Fragrance House, DSM-Firmenich Taps Fine Fragrance President

 

Swiss fragrance company Givaudan SA will acquire Brazilian fragrance house Vollmens Fragrances, as DSM-Firmenich names Jonathan Simon president of fine fragrance.

Product ‘Dupes’ Increasingly Popular Among Price-Wary Consumers Across Globe – Survey

 

Twenty-eight percent of global consumers polled in a survey included in the report, 'The State of Fashion: Beauty,' have ‘consciously’ purchased product dupes, while 53% are open to buying them; growing acceptance of knock-off products is driven in part by inflation.

US Consumer Health Sector Vigilant To Avoid Stumbling On Trump’s Tariff Twists And Turns

 

In remarks at recent investor conference reflecting comments from across the US consumer health sector, Kenvue chief Thibaut Mongon says, “I'm going to state the obvious. The environment is very fluid.”

More from Business

Growing With Purpose – Inside Kenvue’s ‘Healthy Lives Mission’

 
• By 

HBW Insight speaks to Kenvue's global head of sustainability, Jennifer Duran, about the company's “Healthy Lives Mission,” including insights into how the firm is decarbonizing its supply chain, reducing the use of plastics and embedding sustainability into the design of new products.

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.

Interparfums Inks Fragrance License Deal With Parisian Fashion Brand Longchamp

 

New York-based Interparfums has signed a deal with Parisian firm Longchamp – known for its leather goods – for the creation and distribution of fragrance lines.